The Role of BNP in Predicting Outcomes in Pulmonary Embolism
Author Information
Author(s): Coutance Guillaume, Le Page Olivier, Lo Ted, Hamon Martial
Primary Institution: Centre Hospitalier Universitaire de Caen
Hypothesis
Does elevated brain natriuretic peptide (BNP) predict short-term mortality and serious adverse events in patients with acute pulmonary embolism?
Conclusion
Elevated BNP levels can help identify patients with acute pulmonary embolism at high risk of death and adverse outcomes.
Supporting Evidence
- Elevated BNP levels were significantly associated with short-term all-cause mortality.
- The negative predictive value of normal BNP levels was found to be 99%.
- Increased BNP levels were linked to a higher risk of serious adverse events.
Takeaway
If a patient has high levels of a substance called BNP, they might be more likely to have serious problems from a blood clot in their lungs.
Methodology
A systematic review and meta-analysis of studies examining the relationship between BNP levels and outcomes in patients with acute pulmonary embolism.
Potential Biases
Potential bias due to retrospective definitions of BNP cutoff values and variations across studies.
Limitations
The analysis could not determine the incremental value of BNP over other risk factors due to lack of individual data.
Participant Demographics
Demographics were homogenous across studies, with most patients having a confirmed diagnosis of pulmonary embolism.
Statistical Information
P-Value
6.57
Confidence Interval
95% CI 3.11 to 13.91
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website